Skip to main content
Explore URMC

Jason Zittel, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Office: (585) 275-5823

Fax: (585) 273-1051

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Cancer, Hospital Medicine


As a dually trained geriatrician and medical oncologist my focus is not only on treating cancer, but the patient as a whole. Every patient no matter their age has individual needs, preferences and goals which I strive to understand so that I am able to provide the highest quality care possible.




    MD | Pennsylvania State College of Medicine

    Post-doctoral Training & Residency

    07/01/2017 - 06/30/2019
    Fellowship in Hematology & Oncology at University of Rochester Medical Center

    07/01/2016 - 06/30/2017
    Fellowship in Geriatric Medicine at University of Rochester Medical Center

    07/01/2013 - 06/24/2015
    Residency in Internal Medicine at University of Rochester Medical Center

    06/13/2012 - 06/30/2013
    Internship in Internal Medicine at University of Rochester Medical Center

    VIEW ALL expand_more


    BJ Kennedy Award for Best Poster
    Sponsor: International Society of Geriatric Oncology
    Location: Annual Conference, Amsterdam, Netherlands

    The Elaine and Irwin Karron Memorial Prize for Excellence in Geriatrics

    Clinical Trials

    A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients With Treatment Naïve Metastatic Pancreatic Cancer (GIANT)

    Lead Researcher: Jason Zittel

    This phase II trial compares two treatment combinations: gemcitabine hydrochloride and nab-paclitaxel, or fluorouracil, leucovorin calcium, and liposomal irinotecan in older patients with pancreatic cancer that has spread to other places in the body (metastatic). Drugs used in chemotherapy, such as gemcitabine hydrochloride, nab-paclitaxel, fluorouracil, leucovorin calcium, and liposomal irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This study may help doctors find out which treatment combination is better at prolonging life in older patients with metastatic pancreatic cancer.

    View Study Details


    Journal Articles

    Kadambi S, Loh KP, Dunne R, Magnuson A, Maggiore R, Zittel J, Flannery M, Inglis J, Gilmore N, Mohamed M, Ramsdale E, Mohile S. "Older adults with cancer and their caregivers - current landscape and future directions for clinical care." Nature reviews. Clinical oncology.. 2020 Sep 2; Epub 2020 Sep 02.

    DiGiovanni G, Mousaw K, Lloyd T, Dukelow N, Fitzgerald B, D'Aurizio H, Loh KP, Mohile S, Ramsdale E, Maggiore R, Zittel J, Kadambi S, Magnuson A. "Development of a telehealth geriatric assessment model in response to the COVID-19 pandemic." Journal of geriatric oncology.. 2020 Apr 17; Epub 2020 Apr 17.

    Loh KP, Kaushik R, Mohile SG, Ogie S, Kadambi S, Zittel J, Yousefi-Nooraie R, Moorthi K, Patil A, Sanapala C, Yang S, Ramsdale E. "Speeding the dissemination and implementation of geriatric assessment: What we can learn from the business world." Journal of geriatric oncology.. 2020 Mar 24; Epub 2020 Mar 24.

    Books & Chapters

    Chapter Title: Comorbidity in Aging and Cancer
    Book Title: Geriatric Oncology
    Author List: Ramsdale E.E., Zittel J., Sarfati D
    Published By: Springer 2018